Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ovafuze
- Development stage
- Unknown
- Lead developer
- Exeltis
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Ovafuze is an oral nutraceutical and dietary supplement developed by Ordain Health Care (a subsidiary of Exeltis India, part of Insud Pharma) to support women's reproductive health, ovarian function, and fertility. It is formulated as a multi-ingredient tablet containing a comprehensive blend of vitamins, minerals, amino acids, and antioxidants, including Myo-Inositol, L-Arginine, L-Carnitine, Coenzyme Q10, Superoxide Dismutase (from Cucumis melo fruit extract), Alfacalcidol, Benfotiamine, L-Methylfolate, Methylcobalamin, Lycopene, Piperine, and essential minerals (Iron, Zinc, Selenium, Chromium, and Iodine). Ovafuze works synergistically to regulate hormonal balance, improve insulin sensitivity, reduce oxidative stress, and enhance oocyte quality and mitochondrial energy production, making it beneficial for women experiencing Polycystic Ovarian Syndrome (PCOS) or undergoing assisted reproductive technologies (ART).
- Brand names
- Ovafuze
02
Targets
INSR (Insulin receptor)NOS1 (nNOS)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Ovafuze.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ovafuze.